MSB 10.4% $1.49 mesoblast limited

Nice thought, but it won't pass muster. MSB may be receiving...

  1. 332 Posts.
    lightbulb Created with Sketch. 17
    Nice thought, but it won't pass muster. MSB may be receiving recurring revenue by then but it is highly unlikely to be more than costs. If revenue is higher it will be in he form of partnership up-front costs/bio-bucks, so it won't be considered self-sustaining.

    Add a few months to a year and I strongly agree with you, although I'm not sure what length track record is required to satisfy the investment criteria of our old friend @madamswer
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.